儿童和青少年Spitz样增殖性病变的临床特征与结局
该回顾性队列研究纳入波士顿儿童医院1994年1月1日至2012年10月23日期间年龄小于20岁、组织病理学确诊为Spitz样增殖性病变的595例患者(共622处病变)。中位随访4.1年期间无相关死亡,但研究受限于黑色素瘤例数少且仅限单一儿科机构。作者认为,基于该队列临床惰性行为,应重新考虑对表现普通的Spitz痣儿童和青少年采取积极处理建议。
要点
- 622处Spitz样增殖性病变中,典型512处(82.3%)、非典型107处(17.2%)、黑色素瘤3处(0.5%)。
- 典型、非典型与黑色素瘤的中位活检年龄分别为7.4、7.2和17.2岁,典型或非典型 vs 黑色素瘤的活检年龄差异显著(P < 0.01)。
- 切缘阳性样本(n=153)中,典型病变再切除55%(54/98)、非典型77%(41/53)、黑色素瘤100%(2/2);6例前哨淋巴结活检中3例淋巴结黑色素细胞阳性。
核心结论
- Spitz肿瘤在儿科人群中结局显著良性,但本研究受限于黑色素瘤例数少且仅限单一儿科机构。
- 作者认为,基于该队列临床惰性行为,应重新考虑对表现普通的Spitz痣儿童和青少年采取积极处理建议。
研究设计与样本
- 回顾性队列研究,纳入波士顿儿童医院1994年1月1日至2012年10月23日期间年龄小于20岁、组织病理学确诊为Spitz样增殖性病变的患者。
- 共纳入595例患者、622处Spitz样增殖性病变,中位年龄7.4岁(四分位距4.6-11.7)。
主要发现
- 622处增殖性病变中,典型512处(82.3%)、非典型107处(17.2%)、黑色素瘤3处(0.5%)。
- 典型、非典型和黑色素瘤的中位活检年龄分别为7.4、7.2和17.2岁,典型或非典型 vs 黑色素瘤的活检年龄差异显著(P < 0.01)。
- 切缘阳性样本(n=153)中,典型病变再切除55%(54/98)、非典型77%(41/53)、黑色素瘤100%(2/2)。
- 6例患者行前哨淋巴结活检,其中3例淋巴结黑色素细胞阳性。
- 全队列中位随访4.1年期间无相关死亡。
临床怎么用
- 作者认为,基于该队列临床惰性行为,应重新考虑对表现普通的Spitz痣儿童和青少年采取积极处理建议。
局限性
- 本研究受限于黑色素瘤例数少。
- 本研究受限于仅限单一儿科机构。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Spitzoid proliferations range from Spitz naevi to melanomas. There are few studies describing clinical features and outcomes in the paediatric population. OBJECTIVES: To determine the clinical features and outcomes of a large paediatric cohort with histopathologically confirmed Spitz tumours. METHODS: This was a retrospective cohort study of patients seen at Boston Children's Hospital who were aged < 20 years and had a histopathological diagnosis of spitzoid proliferation from 1 January 1994 to 23 October 2012. RESULTS: In total 595 patients with 622 spitzoid proliferations were identified (median age 7·4 years, interquartile range 4·6-11·7). Overall 512 proliferations (82·3%) were typical, 107 (17·2.%) were atypical and three (0·5%) were melanomas. The median ages at biopsy were 7·4, 7·2 and 17·2 years, respectively, and there was a significant difference in age at biopsy for patients with typical or atypical proliferations vs. melanoma (P < 0·01). Among samples with positive margins (n = 153), 55% (54 of 98) of typical proliferations, 77% (41 of 53) of atypical proliferations and 100% (two of two) of melanomas were re-excised. Six patients had sentinel lymph node biopsy performed, with three patients demonstrating nodes positive for melanocytic cells. Within a median follow-up of 4·1 years for the full cohort there were no related deaths. CONCLUSIONS: Spitz tumours have strikingly benign outcomes in the paediatric population, although this study is limited by the low number of melanomas and restriction to a single paediatric institution. Aggressive management recommendations should be reconsidered for children and adolescents with banal-appearing Spitz naevi, based on the clinically indolent behaviour in this cohort.
引用
- Bartenstein DW, Fisher JM, Stamoulis C, et al. Clinical features and outcomes of spitzoid proliferations in children and adolescents. Br J Dermatol. 2019. PMID: 30467833. doi:10.1111/bjd.17450
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。